Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β

Journal of Viral Hepatitis

Volumn 8, Issue 6, 2001, Pages 430-437

  Kanzler, S ^a   Baumann, M ^b   Schirmacher, P ^c   Dries, V ^c   Bayer, E ^a   Gerken, G ^b   Dienes, H P ^c   Lohse, A W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cirrhosis; Fibrogenesis; Liver biopsy; Prognosis; Transforming growth factor beta

Indexed keywords

AMINOTRANSFERASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BIOASSAY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROGENESIS; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER SINUSOID; MALE; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; VIRUS LOAD;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; VIRAL LOAD;

EID: 0035552143     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00314.x     Document Type: Article

References (37)

1. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study
2. 45-Year follow-up of hepatitis C virus infection in healthy young adults
3. The natural history of community-acquired hepatitis C in the United States
4. Natural history of liver fibrosis progression in patients with chronic hepatitis C
5. Natural history of hepatitis C
6. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975
7. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
8. Clinical outcomes after transfusion-associated hepatitis C
9. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
10. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis
11. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
12. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis
13. Transforming growth factor beta 1-regulated gene expression of Ito cells
14. Stimulation of the collagen alpha 1 (I) endogenous gene and transgene in carbon tetrachloride-induced hepatic fibrosis
15. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
16. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice
17. TGF-β1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
18. Transforming growth factors beta-1 and alpha in chronic liver disease
19. Increased transforming growth factor-β1 gene expression in human liver disease
20. Transforming growth factor-beta 1 in chronic hepatitis C
21. Transforming growth factor beta 1. In situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon
22. Quantitative analysis of transforming growth factor β1 messenger RNA in the liver of patients with chronic hepatitis C. Absence of correlation between high levels and severity of disease
23. Serum concentrations of sIL-2R, IL-6, TGF-β1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha
24. Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-alpha therapy. Association with regression of hepatic fibrosis
25. Urinary transforming growth factor β1 levels in hepatitis C virus-related chronic liver disease. Correlation between high levels and severity of disease
26. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
27. Histological grading and staging of chronic hepatitis
28. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies
29. Transforming growth factor-β1 in autoimmune hepatitis. Correlation of liver tissue expression and serum levels with disease activity
30. Clinical evaluation of a single reaction, diagnostic polymerase reaction assay for the detection of hepatitis C virus RNA
31. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment
32. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells
33. Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection
34. Host genetic factors influence disease progression in chronic hepatitis C
35. Genotypic variation in the transforming growth factor-beta1 gene. Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
36. Regulation of immune responses by TGF-beta
37. Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro